The availability of a substandard drug for a bacterial infection has been revealed in the market. The Drug Regulatory Authority of Pakistan (DRAP) has declared a batch of ‘Incip Infusion’ drip as substandard.
According to the details, the Drug Regulatory Authority of Pakistan (DRAP) has issued a product recall alert for Incip infusion drip, and Central Drug Lab Karachi has declared a batch of Incip infusion substandard.
Tests found unwanted particles in the infusion drips of an infected batch of Incip Infusion.
Incip 200 mg Infusion is used to treat bacterial infections and is manufactured by Inventor Pharma Karachi.
DRAP says substandard antibiotic ingestion can cause severe reactions, which can be fatal, the patient can develop sepsis, and the infection can worsen.
Drug Regulatory Authority of Pakistan (DRAP) has warned that the use of substandard antibiotics can affect the patient’s body organs and tissues when the infection is severe.
DRAP has stopped the market supply and directed the company to withdraw its affected batch from the market.
Drug Regulatory Authority of Pakistan (DRAP) has asked chemists to check stock to stop the sale of the affected batch of Incip Infusion, and that chemists and pharmacies return the affected batch of Incip Infusion to the company, and doctors not to allow patients to use the affected batch of Incip Infusion.